Viatris Readies Restasis Launch – So Where Are The Others?

‘No Remaining Legal Or Regulatory Barriers’ Notes F-T-M Viatris

 
• By Dean Rudge
  
blue eye
Viatris/Mylan had worked for "nearly a decade" on its ANDA • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Products

More from Generics Bulletin